Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 16/20 | 0.66 |
| ▸ | MAOA | P21397 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | CASP7 | P55210 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29406299 | 1.00 | GPR35 (0.66) | GPR35MAOAHPGDMAOBUSP2 | |
| SCHEMBL25444789 | 0.86 | GPR35 (0.47) | GPR35MAOAHPGDMAOBUSP2 | |
| SCHEMBL16995491 | 0.86 | GPR35 (0.47) | GPR35MAOAHPGDMAOBUSP2 | |
| SCHEMBL23155088 | 0.86 | MAOB (0.54) | GPR35MAOAHPGDMAOBUSP2 | |
| SCHEMBL27718715 | 0.85 | GPR35 (0.62) | GPR35MAOAHPGDMAOBUSP2 | |
| SCHEMBL14688014 | 0.84 | GPR35 (0.48) | GPR35MAOAHPGDMAOBUSP2 | |
| SCHEMBL14688013 | 0.84 | GPR35 (0.48) | GPR35MAOAHPGDMAOBUSP2 | |
| SCHEMBL8571484 | 0.84 | GPR35 (0.45) | GPR35MAOAHPGDMAOBUSP2 | |
| SCHEMBL15288853 | 0.83 | GPR35 (0.41) | GPR35MAOAHPGDUSP2POLB | |
| SCHEMBL21316428 | 0.83 | GPR35 (0.58) | GPR35MAOAHPGDMAOBUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346805-A1 | OPTICAL METHOD TO ENHANCE DETECTION VISIBILITY USING BRIGHT EMISSIVE PROBE | KLA CORP (US) | 2025-11-13 | — | — | US | claimed |
| WO-2025235337-A1 | OPTICAL METHOD TO ENHANCE DETECTION VISIBILITY USING BRIGHT EMISSIVE PROBE | KLA CORPORATION (US) | 2025-11-13 | — | — | WO | claimed |
| WO-2025050003-A1 | HIGH-THROUGHPUT CONDENSATE MODULATOR SCREEN | TRANSITION BIO, INC. (US) | 2025-03-06 | — | — | WO | claimed |
| US-20230149478-A1 | COMPOSITIONS AND METHODS FOR DIABETES TREATMENT | THE GENERAL HOSPITAL CORPORATION | 2023-05-18 | — | — | US | claimed |
| EP-3947310-B1 | COATED SUBSTRATE AND PROCESS OF PREPARATION | PILKINGTON GROUP LTD (GB) | 2023-03-22 | — | — | EP | claimed |
| EP-4125829-A2 | COMPOSITIONS AND METHODS FOR DIABETES TREATMENT | THE GENERAL HOSPITAL CORPORATION (US) | 2023-02-08 | — | — | EP | claimed |
| US-20220298557-A1 | METHOD FOR DESIGNING A PROBE COMBINATION | EIKEN CHEMICAL (JP) | 2022-09-22 | — | — | US | claimed |
| US-20220298558-A1 | KIT FOR DETECTING A MUTATED TARGET BASE SEQUENCE | EIKEN CHEMICAL (JP) | 2022-09-22 | — | — | US | claimed |
| US-11390911-B2 | Method for detecting a target base sequence | EIKEN KAGAKU KABUSHIKI KAISHA (JP) | 2022-07-19 | — | — | US | claimed |
| US-20220153634-A1 | COATED SUBSTRATE AND PROCESS OF PREPARATION | PILKINGTON GROUP LIMITED (GB) | 2022-05-19 | — | — | US | claimed |
| US-20150369797-A1 | METHOD FOR IMAGING CELL USING FLUORESCENCE-LABELED SUGAR DERIVATIVE HAVING COUMARIN DERIVATIVE BOUND THERETO, AND IMAGING AGENT | HIROSAKI UNIVERSITY (JP) | 2015-12-24 | — | — | US | claimed |
| US-20150368712-A1 | UNIVERSAL NUCLEIC ACID PROBE SET AND METHOD FOR UTILIZATION THEREOF | NIPPON STEEL & SUMIKIN ECO TECH CORP (JP) | 2015-12-24 | — | — | US | claimed |
| EP-2905620-A1 | METHOD FOR IMAGING CELL USING FLUORESCENCE-LABELED SUGAR DERIVATIVE HAVING COUMARIN DERIVATIVE BOUND THERETO, AND IMAGING AGENT | Hirosaki University (JP) | 2015-08-12 | — | — | EP | claimed |
| US-20140178876-A1 | UNIVERSAL NUCLEIC ACID PROBE SET AND METHOD FOR UTILIZATION THEREOF | NIPPON STEEL & SUMIKIN ECO-TECH CORPORATION (JP) | 2014-06-26 | — | — | US | claimed |
| US-20130065237-A1 | NOVEL MIXTURES FOR ASSAYING NUCLEIC ACID, NOVEL METHOD OF ASSAYING NUCLEIC ACID WITH THE USE OF THE SAME AND NUCLEIC ACID PROBE TO BE USED THEREFOR | NIPPON STEEL & SUMIKIN ECO-TECH CORPORATION (JP) | 2013-03-14 | — | — | US | claimed |
| US-20110224417-A1 | NOVEL MIXTURES FOR ASSAYING NUCLEIC ACID, NOVEL METHOD OF ASSAYING NUCLEIC ACID WITH THE USE OF THE SAME AND NUCLEIC ACID PROBE TO BE USED THEREFORE | KANKYO ENGINEERING CO., LTD. (JP) | 2011-09-15 | — | — | US | claimed |
| US-20110212442-A1 | UNIVERSAL NUCLEIC ACID PROBE SET AND METHOD FOR UTILIZATION THEREOF | NIPPON STEEL KANKYO ENGINEERING CO., LTD. (JP) | 2011-09-01 | — | — | US | claimed |
| EP-2333059-A1 | UNIVERSAL NUCLEIC ACID PROBE SET AND METHOD FOR UTILIZATION THEREOF | Nippon Steel Kankyo Engineering Co., Ltd. (JP) | 2011-06-15 | — | — | EP | claimed |
| US-7951604-B2 | Mixtures for assaying nucleic acid, novel method of assaying nucleic acid with the use of the same and nucleic acid probe to be used therefor | KANKYO ENGINEERING CO., LTD. (JP) | 2011-05-31 | — | — | US | claimed |
| US-20100015719-A1 | NOVEL MIXTURES FOR ASSAYING NUCLEIC ACID, NOVEL METHOD OF ASSAYING NUCLEIC ACID WITH THE USE OF THE SAME AND NUCLEIC ACID PROBE TO BE USED THEREFOR | KANKYO ENGINEERING CO., LTD. (JP) | 2010-01-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150369797-A1 | METHOD FOR IMAGING CELL USING FLUORESCENCE-LABELED SUGAR DERIVATIVE HAVING COUMARIN DERIVATIVE BOUND THERETO, AND IMAGING AGENT | FUT6, LGALS7; LGALS7B, LGALS4 | GPR35 4026/4885MAOA 4374/4885HPGD 2143/4885 |
| US-20230149478-A1 | COMPOSITIONS AND METHODS FOR DIABETES TREATMENT | SLC2A1, G6PD, HK1 | GPR35 2738/4885MAOA 2441/4885HPGD 586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.